BRD2 and hypogonadotropic hypogonadism: Conversely, acquired central hypogonadism results in a less significant effect on Sertoli cell biomarkers, likely due to the fact that sufficient FSH activity induced normal Sertoli cell proliferation during fetal and neonatal periods leading to an adequate mass of Sertoli cells, as reflected by normal testicular volume in most cases (35).